The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids
Open accessAbstract
Glucocorticoids depress bone formation by inhibiting osteoblastogenesis and increasing osteoblast apoptosis. However, the role of bone resorption in the initial rapid phase of bone loss characteristic of glucocorticoid-induced osteoporosis is unexplained, and the reason for the efficacy of bisphosphonates in this condition remains unknown. We report that in murine osteoclast cultures, glucocorticoids prolonged the baseline survival of osteoclasts and antagonized bisphosphonate-induced caspase activation and apoptosis by a glucocorticoid receptor–mediated action. Consistent with the in vitro evidence, in a murine model of glucocorticoid-induced osteoporosis, the number of cancellous osteoclasts increased, even though osteoclast progenitor number was reduced. Moreover, in mice receiving both glucocorticoids and bisphosphonates, the expected proapoptotic effect of bisphosphonates on osteoclasts was abrogated, as evidenced by maintenance of osteoclast numbers and, additionally, loss of bone density. In contrast, bisphosphonate administration prevented glucocorticoid-induced osteoblast apoptosis. These results indicate that the early loss of bone with glucocorticoid excess is caused by extension of the life span of pre-existing osteoclasts, an effect not preventable by bisphosphonates. Therefore, the early beneficial effects of these agents must be due, in part, to prolonging the life span of osteoblasts.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parfitt, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. A., Malluche, H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020617 · Cited by 5,016
Self-citationManolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0395 · Cited by 2,568
Self-citationWeinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2799 · Cited by 1,753 · cited 7×
“We have reported previously that glucocorticoid administration to mice for 27 days (a period representing chronic rather than short-term drug exposure) decreases the number of osteoblast and osteoclast progenitors, decreases the cancellous osteoblast and osteoclast perimeters, and increases osteoblast apoptosis (20).”
InfluentialSelf-citationUnbalanced Repeated-Measures Models with Structured Covariance Matrices
Jennrich, R. I., & Schluchter, M. D. (1986) · Biometrics · doi:10.2307/2530695 · Cited by 1,325
Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
Saag, K. G., Emkey, R., Schnitzer, T. J., Brown, J. P., Hawkins, F., Goemaere, S., Thamsborg, G., Liberman, U. A., Delmas, P. D., Malice, M.-P., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390502 · Cited by 1,258
Luckman, S. P., Hughes, D. E., Coxon, F. P., Russell, R. G. G., & Dr. Rogers, M. J. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.4.581 · Cited by 1,176
Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin
Plotkin, L. I., Weinstein, R. S., Parfitt, A. M., Roberson, P. K., Manolagas, S. C., & Bellido, T. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6800 · Cited by 890 · cited 2×
“Despite the uncertainty about the role of bone resorption in the pathogenesis of osteoporosis induced by long-term glucocorticoid administration, the benefits of bisphosphonate therapy in this disorder have been ascribed solely to antiresorptive effects and preservation of, or increases in, bone density (13, 16, 17),…”
Self-citationEstrogen promotes apoptosis of murine osteoclasts mediated by TGF–β
Hughes, D. E., Dai, A., Tiffee, J. C., Li, H. H., Mundy, G. R., & Boyce, B. F. (1996) · Nature Medicine · doi:10.1038/nm1096-1132 · Cited by 813
Reid, D. M., Hughes, R. A., Laan, R. F. J. M., Sacco-Gibson, N. A., Wenderoth, D. H., Adami, S., Eusebio, R. A., & Devogelaer, J.-P. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.6.1006 · Cited by 592
Bone loss in response to long-term glucocorticoid therapy
LoCascio, V., Bonucci, E., Imbimbo, B., Ballanti, P., Adami, S., Milani, S., Tartarotti, D., & DellaRocca, C. (1990) · Bone and Mineral · doi:10.1016/0169-6009(91)90139-q · Cited by 384
Reid, I. R., Alexander, C. J., King, A. R., & Ibbertson, H. K. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92721-3 · Cited by 341
Jilka, R. L., Weinstein, R. S., Takahashi, K., Parfitt, A. M., & Manolagas, S. C. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118600 · Cited by 339
Self-citationPerspectives bone histomorphometry in glucocorticoid-induced osteoporosis
Dr. Dempster, D. W. (1989) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650040202 · Cited by 319
O'Brien, C. A., Gubrij, I., Lin, S.-C., Saylors, R. L., & Manolagas, S. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.19301 · Cited by 313
Self-citationCarbonare, L. D., Arlot, M. E., Chavassieux, P. M., Roux, J. P., Portero, N. R., & Meunier, P. J. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.1.97 · Cited by 309
Weinstein, R. S., & Manolagas, S. C. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00420-9 · Cited by 250
Self-citationVisualization of bisphosphonate-induced caspase-3 activity in apoptotic osteoclasts in vitro
Benford, H. L., McGowan, N. W. A., Helfrich, M. H., Nuttall, M. E., & Rogers, M. J. (2001) · Bone · doi:10.1016/s8756-3282(01)00412-4 · Cited by 235
Dempster, D. W., Arlot, M. A., & Meunier, P. J. (1983) · Calcified Tissue International · doi:10.1007/bf02405069 · Cited by 233
Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone
Siris, E. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.3.961 · Cited by 227
Mifepristone (RU 486) -- A Modulator of Progestin and Glucocorticoid Action
Wood, A. J. J., Spitz, I. M., & Bardin, C. W. (1993) · New England Journal of Medicine · doi:10.1056/nejm199308053290607 · Cited by 221
Jilka, R. L., Takahashi, K., Munshi, M., Williams, D. C., Roberson, P. K., & Manolagas, S. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1039 · Cited by 212
Self-citationGlucocorticoid-Induced Osteoporosis
Weinstein, R. S. (2001) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/a:1010007108155 · Cited by 189
Self-citationCorticosteroid-Induced Bone Loss in Men
Pearce, G. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.3.801 · Cited by 184
Borton, A. J., Frederick, J. P., Datto, M. B., Wang, X.-F., & Weinstein, R. S. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.10.1754 · Cited by 179
Self-citationPATHOGENESIS AND TREATMENT OF STEROID OSTEOPOROSIS
REID, I. R. (1989) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1989.tb03730.x · Cited by 171
Boutsen, Y., Jamart, J., Esselinckx, W., & Devogelaer, J. P. (2001) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2001.16.1.104 · Cited by 161
Gregorio, G. B. D., Yamamoto, M., Ali, A., Abe, E., Roberson, P. K., Manolagas, S. C., & Jilka, R. L. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11653 · Cited by 127
Self-citationWeinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1997) · Endocrinology · doi:10.1210/endo.138.9.5359 · Cited by 126
Self-citationDose-Response Relationships for Alendronate Treatment in Osteoporotic Elderly Women
Bone, H. G. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.1.265 · Cited by 114
Markers of bone metabolism in postmenopausal women with rheumatoid arthritis
Hall, G. M., Spector, T. D., & Delmas, P. D. (1995) · Arthritis & Rheumatism · doi:10.1002/art.1780380705 · Cited by 113
Osteoclast precursors as leukocytes: importance of the area code
PARFITT, A. M. (1998) · Bone · doi:10.1016/s8756-3282(98)00140-9 · Cited by 84
Self-citationBone histomorphometry and structure in corticosteroid treated chronic active hepatitis.
Stellon, A. J., Webb, A., & Compston, J. E. (1988) · Gut · doi:10.1136/gut.29.3.378 · Cited by 83
Glucocorticoids stimulate resorption in fetal rat parietal bones in vitro
Gronowicz, G., McCarthy, M. B., & Raisz, L. G. (1990) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650051206 · Cited by 76
Defranco, D. J., Lian, J. B., & Glowacki, J. (1992) · Endocrinology · doi:10.1210/endo.131.1.1611989 · Cited by 50
Studies of Bone Tissue in Rats Treated by Prednisolone and 1,25-(OH)2D3
Lindgren, J., Johnell, O., & DeLuca, H. F. (1983) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-198312000-00041 · Cited by 40
Research works printed but not linked: 4
- 10.1210/en.138.9.4013 · doi:10.1210/en.138.9.4013 · Paper page
- 2001, Stata Corporation College Station, Texas, USA, 3, 44
- 10.1210/er.21.2.115 · DOI
- 10.1210/en.131.1.114 · doi:10.1210/en.131.1.114 · Paper page
Cited by
Matrix-embedded cells control osteoclast formation
Xiong, J., Onal, M., Jilka, R. L., Weinstein, R. S., Manolagas, S. C., & O'Brien, C. A. (2011) · Nature Medicine · doi:10.1038/nm.2448 · Cited by 1,304
“And third, administration of glucocorticoids potently reduces the number of osteoblasts on bone, as well as the abundance of their precursors in the bone marrow, but not the number of osteoclast”
BackgroundSelf-citationManolagas, S. C. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0024 · Cited by 1,200
Self-citationO’Brien, C. A., Jia, D., Plotkin, L. I., Bellido, T., Powers, C. C., Stewart, S. A., Manolagas, S. C., & Weinstein, R. S. (2004) · Endocrinology · doi:10.1210/en.2003-0990 · Cited by 771
Self-citationSkeletal Involution by Age-associated Oxidative Stress and Its Acceleration by Loss of Sex Steroids
Almeida, M., Han, L., Martin-Millan, M., Plotkin, L. I., Stewart, S. A., Roberson, P. K., Kousteni, S., O'Brien, C. A., Bellido, T., Parfitt, A. M., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702810200 · Cited by 706
Self-citationGlucocorticoid-Induced Bone Disease
Weinstein, R. S. (2011) · New England Journal of Medicine · doi:10.1056/nejmcp1012926 · Cited by 694
Self-citation
Metadata
- Authors
- Weinstein, R. S., Chen, J.-R., Powers, C. C., Stewart, S. A., Landes, R. D., Bellido, T., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C.
- Venue
- Journal of Clinical Investigation
- Published
- 2002-04-15
- Volume
- 109
- Issue
- 8
- Pages
- 1041-1048
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W4240799970
- Cited by
- 313
- References
- 35
- FWCI
- 5.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.